Antithrombotic therapy after iliac vein stenting / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
;
(6): 131-136, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-828536
ABSTRACT
Stenting for iliac vein stenosis or compression has become a common therapeutic approach in recent years. The antithrombotic therapy after the stent deployment, however, reaches no consensus. Medications strategies and patients' prognoses differ in non-thrombotic, acute thrombotic and chronic thrombotic these three circumstances. Non-thrombotic patients usually possess satisfactory stent patency whatever antithrombotic therapy is used. Anticoagulant is the basic medication for acute thrombotic patients, benefits from additional antiplatelet drug remains to be clarified. In terms of chronic thrombotic patients, their prognoses are unsatisfactory under all antithrombotic therapies. In this review, we outlined the recent progress of antithrombotic therapy after iliac vein stenting, aiming to provide feasible medication plans for each circumstance.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
General Surgery
/
Vascular Patency
/
Stents
/
Treatment Outcome
/
Constriction, Pathologic
/
Therapeutic Uses
/
Drug Therapy
/
Fibrinolytic Agents
/
Iliac Vein
Limits:
Humans
Language:
Chinese
Journal:
Journal of Zhejiang University. Medical sciences
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS